Viewing StudyNCT01584440



Ignite Creation Date: 2024-05-06 @ 12:28 AM
Last Modification Date: 2024-10-26 @ 10:50 AM
Study NCT ID: NCT01584440
Status: COMPLETED
Last Update Posted: 2021-11-26
First Post: 2012-04-23

Brief Title: Efficacy Safety and Tolerability Study of AVP-923 DextromethorphanQuinidine for Treatment of Symptoms of Agitation in Participants With Alzheimers Disease
Sponsor: Avanir Pharmaceuticals
Organization: Avanir Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Alzheimers Disease
Agitation
Keywords:
Name View
Safety View
AVP-923-20 View
AVP-923-30 View
AVP-923 View
Dextromethorphan View
Quinidine View
Neuropsychiatric Inventory View
Aggression View
Efficacy View